EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Georg Lutter
Friedhelm Beyersdorf
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lutter, G.
Right arrow Articles by Beyersdorf, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lutter, G.
Right arrow Articles by Beyersdorf, F.

Eur J Cardiothorac Surg 2000;18:38-45
© 2000 Elsevier Science NL


Evaluation of the indirect revascularization method after 3 months chronic myocardial ischemia

Georg Luttera, Juergen Martina, Peter Derna, Koppany Saraia, Manfred Olschewskib, Patrick von Samsona, Manuela Bürklea, Friedhelm Beyersdorfa

a Division of Cardiovascular Surgery, Albert-Ludwigs-University, School of Medicine, Freiburg, Germany
b Division of Medical Biometrics, Albert-Ludwigs-University, School of Medicine, Medical Center, Hugstetter Strasse 55, D-79106 Freiburg, Germany

Received 12 October 1999; received in revised form 6 March 2000; accepted 13 March 2000.

Corresponding author. Tel.: +49-761-270-2818, fax: +49-761-270-2550
e-mail: lutter{at}ch11.ukl.uni-freiburg.de

Objective: The long-term effectiveness of transmyocardial laser revascularization (TMLR) was evaluated in the setting of a severe left anterior descending artery (LAD) stenosis. Methods: To employ the chronic ischemic model, pigs underwent three operative procedures over a 13-week period. In the first operation, an operative stenosis of the LAD was created. One week later, the animals were studied at baseline by analyzing different parameters of perfusion (microspheres), function and ECG changes. Afterwards, pigs were randomized into one of three different experimental groups: animals in laser group 1 received one laser channel (n=9) and laser group 2 two channels per cm2 (n=6) in the LAD territory (using a CO2-laser). Animals of the ischemic group (n=12) underwent the same procedures without TMLR-treatment. Twelve weeks later, the animals were re-studied (third operation) and killed. Additional analysis of myocardial water content and histochemistry was performed. Results: Chronic myocardial ischemia and regional myocardial blood flow (RMBF) in laser group 2 revealed relatively higher RMBF values compared with the ischemic group (P=0.015), after 3 months, but no absolute improvement of perfusion at rest compared with baseline was observed in all experimental groups. Left ventricular stroke work index (LVSWI) at rest and under stress did not show any improvement compared with initial values in all study groups (P not significant). However, laser group 1 demonstrated relatively higher LVSWImax values in comparison with the ischemic group (P=0.013) as did laser group 2 (P=0.017). Regional contractility of the laser groups recovered after 3 months (which was deteriorated shortly after TMLR, P<0.001) and increased under stress compared with baseline (laser 1: P=0.015, laser 2: P=0.017). In contrast, the ischemic group did not show any difference from initial values (P not significant). The lased pigs of group 2 were less prone to intractable ventricular fibrillation (P=0.036 vs. ischemic group), and showed a significant smaller area of necrosis in the area at risk (P=0.012 vs. ischemic group). Conclusions: This model of chronic regional ischemia demonstrates that CO2-laser revascularization significantly ameliorates microperfusion and regional contractility, and diminishes the incidence of ventricular fibrillation and necrosis in the area at risk. However, it does not change the overall perfusion and global LV function.

Key Words: Coronary artery disease • Transmyocardial laser revascularization, Chronic ischemia • Myocardium




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. M. Muhling, Y. Wang, M. Jerosch-Herold, M. M. Cayton, L. S. Wann, M. M. Mirhoseini, and N. M. Wilke
Improved myocardial function after transmyocardial laser revascularization according to cine magnetic resonance in a porcine model
J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 391 - 395.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Saririan and M. J. Eisenberg
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Lutter, T. Attmann, C. Heilmann, P. von Samson, B. von Specht, and F. Beyersdorf
The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts
Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 753 - 761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.